Literature DB >> 31588593

Part II-Clinical presentation, electrophysiologic characteristics, and when and how to ablate atriofascicular pathways and long and short decrementally conducting accessory pathways.

Frederico Soares Correa1,2, Yash Lokhandwala3, Fernando Cruz Filho4, Damián Sánchez-Quintana5, Shumpei Mori6, Robert H Anderson7, Hein J J Wellens8, Eduardo Back Sternick1,2.   

Abstract

Recognition of the presence, location, and properties of unusual accessory pathways for atrioventricular conduction is an exciting, frequently difficult, challenge for the clinical cardiac arrhythmologist. In this second part of our series of reviews relative to this topic, we discuss the steps required to achieve the correct diagnosis and appropriate management in patients with the so-called "Mahaim" variants of pre-excitation. We indicate that, nowadays, it is recognized that these abnormal rhythms are manifest because of the presence of atriofascicular pathways. These anatomical substrates, however, need to be distinguished from the other long and short accessory pathways which produce decremental atrioventricular conduction. The atriofascicular pathways, along with the long decrementally conducting pathways, have their atrial components located within the vestibule of the tricuspid valve. The short decremental pathways, in contrast, can originate in the vestibules of either the mitral or tricuspid valves. As a starting point, careful analysis of the 12-lead electrocardiogram, taken during both sinus rhythm and tachycardias, should precede any investigation in the catheterization room. When assessing the patient in the electrophysiological laboratory, the use of programmed electrical stimulation from different intracardiac locations, combined with entrainment technique and activation mapping, should permit the establishment of the properties of the accessory pathways, and localization of its proximal and distal ends. This should provide the answer to the question "is the pathway incorporated into the circuit underlying the clinical tachycardia". That information is essential for decision-making with regard to need, and localization of the proper site, for catheter ablation.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mahaim; atriofascicular pathway; decremental conduction; long atrioventricular decremental pathway; short atrioventricular decremental pathway; variants of pre-excitation

Year:  2019        PMID: 31588593     DOI: 10.1111/jce.14203

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

Review 1.  Adenosine-A drug with myriad utility in the diagnosis and treatment of arrhythmias.

Authors:  Anunay Gupta; Yash Lokhandwala; Nitish Rai; Amit Malviya
Journal:  J Arrhythm       Date:  2020-12-18

Review 2.  Critical Assessment of the Concepts and Misconceptions of the Cardiac Conduction System over the Last 100 Years: The Personal Quest of Robert H. Anderson.

Authors:  Eduardo Back Sternick; Damián Sánchez-Quintana
Journal:  J Cardiovasc Dev Dis       Date:  2021-01-19

3.  Comprehensive assessment of Mahaim accessory pathways' anatomic distribution.

Authors:  Suat Gormel; Salim Yasar; Erkan Yildirim; Serkan Asil; Veysel Ozgur Baris; Yalcın Gokoglan; Murat Celik; Uygar Cagdas Yuksel; Veysel Kutay Vurgun; Hasan Kutsi Kabul; Sedat Kose
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

4.  High-density mapping of atrial insertion of right lateral retrograde decremental accessory pathway: 3D illustration of accessory atrioventricular conduction network.

Authors:  Philippe Maury; Quentin Voglimacci-Stephanopoli; Franck Mandel; Pauline Parlier; Maxime Beneyto; Anne Rollin
Journal:  HeartRhythm Case Rep       Date:  2021-11-17

5.  Ventricular tachycardia or supraventricular tachycardia?

Authors:  Mohammad Alasti; Tania Pawade; Jeffrey Alison
Journal:  J Arrhythm       Date:  2022-02-04

Review 6.  Mahaim Revisited.

Authors:  Eduardo Back Sternick; Damian Sanchez-Quintana; Hein Jj Wellens; Robert H Anderson
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.